BITRF (Biotron) FCF Margin % : 0.00% (As of Dec. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Biotron FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Biotron's Free Cash Flow for the six months ended in Dec. 2024 was $0.31 Mil. Biotron's Revenue for the six months ended in Dec. 2024 was $0.00 Mil. Therefore, Biotron's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.

As of today, Biotron's current FCF Yield % is 5.67%.

The historical rank and industry rank for Biotron's FCF Margin % or its related term are showing as below:

BITRF's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -127.825
* Ranked among companies with meaningful FCF Margin % only.

Biotron FCF Margin % Historical Data

The historical data trend for Biotron's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotron FCF Margin % Chart

Biotron Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

FCF Margin %

Get a 7-Day Free Trial

Biotron Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
FCF Margin %	Get a 7-Day Free Trial															-55,500.00	-	-	-	-

Competitive Comparison of Biotron's FCF Margin %

For the Biotechnology subindustry, Biotron's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biotron's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biotron's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Biotron's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Biotron FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Biotron's FCF Margin for the fiscal year that ended in Jun. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2024 )	/	Revenue (A: Jun. 2024 )
	=	-2.37	/	0
	=	%

Biotron's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	0.308	/	0
	=	%

Biotron FCF Margin % Related Terms

Thank you for viewing the detailed overview of Biotron's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotron Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotron Ltd (OTCPK:BITRF) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

BIT:Australia

Address

56 Delhi Road, Suite 3.3, North Ryde, Sydney, NSW, AUS, 2113

Website

https://www.biotron.com.au

Biotron Ltd is a biotechnology company. It is engaged in the funding and management of intermediate and applied biotechnology research and development projects. Its antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. Geographically, it operates only in Australia through biotechnology segment.

Biotron Headlines

From GuruFocus

Biotron Drug Effective Against COVID-19 In Animals

By PRNewswire PRNewswire • 11-25-2021